Answers are grounded in this paper and cite their sources.
The cytokinesis-block micronucleus (CBMN) assay is widely used for biomonitoring populations exposed to ionizing radiation as a simpler alternative to the chromosomal aberration (CA) assay. However, evidence regarding the concordance of these two assays under chronic low-dose occupational exposure remains limited and inconsistent. This study aimed to systematically evaluate the agreement and diagnostic performance of the micronucleus (MN) assay relative to the CA assay in a cohort of medical radiation workers chronically exposed to low doses. In this cross-sectional study, we analyzed 1,226 concurrent MN and CA test results from 321 medical radiation workers. Both assays were performed on the same blood sample from each participant in accordance with national standards (GBZ/T 248-2014; GBZ/T 328-2023). Agreement between the two assays was assessed using Cohen’s kappa statistic, and diagnostic performance (sensitivity, specificity, AUC) was assessed across MN thresholds ranging from 1‰ to 6‰. Although the MN and CA assays were statistically associated (χ² = 8.73, p = 0.003), their agreement was only slight (κ = 0.08). The MN assay showed poor diagnostic accuracy (AUC = 0.579). At the conventional 6‰ threshold, the MN assay demonstrated high specificity (91.2 %) and a high negative predictive value (NPV > 95 %), but very low sensitivity (19.7 %) and a low positive predictive value (PPV) of approximately 11 %. The MN assay shows limited concordance and diagnostic accuracy compared with the CA assay under chronic low-dose exposure conditions and therefore cannot be recommended as a standalone substitute. However, its consistently high NPV supports its use as an efficient rule-out tool within a tiered surveillance strategy, where negative MN results reliably exclude CA-detectable chromosomal damage and positive results trigger confirmatory CA testing. • Assessed MN-CA concordance in 321 medical radiation workers under chronic low-dose exposure. • MN and CA assays demonstrated slight agreement (κ=0.08), and the MN assay showed low diagnostic accuracy (AUC≤0.579). • At the 6‰ threshold, the MN assay showed 19.70 % sensitivity, 91.21 % specificity; and consistently high NPV (>95 %). • The MN assay's high NPV and low PPV (~11 %) support its use as an efficient rule-out tool in a tiered occupational health surveillance model.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: